Table 3.
Microbleeds absent | Microbleeds present | Beta (95% CI) | p | |
---|---|---|---|---|
n | 18 | 12 | – | – |
Amyloid SUVR | 1.25 (0.22) | 1.25 (0.24) | − 0.17 (− 0.51 to 0.18) | 0.33 |
Grey matter volume (% of ICV) | 37.5 (3.2) | 36.6 (2.1) | 0.03 (− 0.23 to 0.27) | 0.88 |
Hippocampal volume (% of ICV) | 0.15 (0.04) | 0.15 (0.02) | 0.17 (− 0.11 to 0.46) | 0.22 |
Log WMH | − 5.1 (1.2) | − 4.7 (0.6) | 0.07 (− 0.28 to 0.42) | 0.68 |
Parietal perfusion SUVR | 0.83 (0.10) | 0.93 (0.11) | 0.42 (0.04–0.79) | 0.03 |
Occipital perfusion SUVR | 0.97 (0.07) | 1.02 (0.06) | 0.35 (− 0.05 to 0.74) | 0.08 |
MTL perfusion SUVR | 0.78 (0.10) | 0.78 (0.07) | 0.19 (− 0.15 to 0.52) | 0.27 |
General linear model with age as a covariate. Microbleed present n = 12 for grey matter and hippocampal volume, otherwise n = 11
Significant findings in bold
ICV intracranial volume, SUVR standardised uptake value ratio, WMH white matter hyperintensities, MTL medial temporal lobe